Drug profile · INN
oxycodone
XTAMPZA ER
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
oxycodone (XTAMPZA ER) is an FDA-listed pharmaceutical active ingredient. Associated with COLLEGIUM PHARMACEUTICAL, INC. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN oxycodone
Brand XTAMPZA ER
Route ORAL
Formulation CAPSULE, EXTENDED RELEASE
Originator COLLEGIUM PHARMACEUTICAL, INC
Related patents
Search patents →Frequently asked questions
What is oxycodone?
oxycodone (XTAMPZA ER) is an FDA-listed pharmaceutical active ingredient. Associated with COLLEGIUM PHARMACEUTICAL, INC. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for oxycodone?
XTAMPZA ER is a marketed brand name for oxycodone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oxycodone?
oxycodone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.